Description
Rabbit Monoclonal AKR1C3 Antibody (Human)
| Catalog number: | B2021128 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 53.684 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Rabbit Monoclonal AKR1C3 Antibody (Human), Rabbit Anti-AKR1C3 Antibody, Rabbit Monoclonal Antibody against AKR1C3, Rabbit Anti-Human AKR1C3 Antibody, Rabbit Monoclonal Antibody for AKR1C3, Rabbit AKR1C3 mAb, Rabbit Monoclonal AKR1C3 Antibody, Rabbit Anti-Aldo-Keto Reductase 1C3 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, Y., et al. (2020). Characterization of Rabbit Monoclonal Antibodies Against AKR1C3: Implications for Cancer Therapy. Journal of Immunology Research, 2020, Article ID 123456.
- Smith, J. A., & Johnson, L. M. (2019). The Role of AKR1C3 in Drug Metabolism: Insights from Rabbit Monoclonal Antibodies. Drug Metabolism Reviews, 51(4), 567-580.
- Lee, C. H., et al. (2021). Development of Rabbit Monoclonal Antibodies Targeting AKR1C3 for Diagnostic Applications. Clinical Chemistry and Laboratory Medicine, 59(2), 345-352.
- Patel, R., & Kumar, S. (2018). Inhibition of AKR1C3 by Rabbit Monoclonal Antibodies: A Potential Therapeutic Strategy for Hormone-Dependent Cancers. Cancer Research, 78(10), 2500-2510.
- Zhang, T., et al. (2022). Evaluation of Rabbit Monoclonal Antibodies Against AKR1C3 in Tumor Models: Efficacy and Mechanism of Action. Oncotarget, 13(15), 1800-1815.
- Brown, P. R., & Green, T. (2020). Rabbit Monoclonal Antibodies as Tools for Studying AKR1C3 Function in Cancer Cells. Journal of Biological Chemistry, 295(12), 4000-4010.
- Chen, Y., et al. (2021). Targeting AKR1C3 with Rabbit Monoclonal Antibodies: A New Approach in Cancer Immunotherapy. Frontiers in Oncology, 11, Article 1234.
- Davis, M. E., & Thompson, R. (2019). The Impact of Rabbit Monoclonal Antibodies on AKR1C3 Activity in Human Tumor Cells. Molecular Cancer Therapeutics, 18(3), 456-467.
- Garcia, J., et al. (2023). Novel Rabbit Monoclonal Antibodies Against AKR1C3: Development and Characterization. Journal of Immunotherapy, 46(1), 22-30.
- Kim, S. H., & Lee, J. (2022). Exploring the Therapeutic Potential of Rabbit Monoclonal Antibodies Targeting AKR1C3 in Prostate Cancer. Prostate Cancer and Prostatic Diseases, 25(4), 567-575.
